Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs
- 1 June 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (6) , 431-441
- https://doi.org/10.1038/nrc823
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- An Episomally MaintainedMDR1Gene for Gene TherapyHuman Gene Therapy, 2001
- Chemoprotection of Hematopoietic Cells by a Mutant P-Glycoprotein Resistant to a Potent Chemosensitizer of Multidrug-Resistant CancersHuman Gene Therapy, 2000
- Delta MGMT-Transduced Bone Marrow Infusion Increases Tolerance to O6-Benzylguanine and 1,3-Bis(2-chloroethyl)1-nitrosourea and Allows Intensive Therapy of 1,3-Bis(2-chloroethyl)-1-nitrosourea-Resistant Human Colon Cancer XenograftsHuman Gene Therapy, 1999
- Expression of the Human Multidrug Resistance and Glucocerebrosidase cDNAs from Adeno-Associated Vectors: Efficient Promoter Activity of AAV Sequences andIn VivoDelivery via LiposomesHuman Gene Therapy, 1996
- Comparison of Efficiency of Infection of Human Gene Therapy Target CellsviaFour Different Retroviral ReceptorsHuman Gene Therapy, 1996
- Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.Journal of Clinical Investigation, 1994
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.The Journal of Experimental Medicine, 1987
- Developmental potential and dynamic behavior of hematopoietic stem cellsCell, 1986